Please find attached Financial Results.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 17.6 pts more than Nifty Microcap 250 and 18.0 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited reported audited financial results for FY26 ending March 31, 2026. Total income was Rs 29,136 lakhs vs Rs 28,971 lakhs in FY25, showing marginal revenue growth of less than 1%. However, Profit After Tax (PAT) improved significantly to Rs 1,104 lakhs from Rs 793 lakhs in the prior year, representing PAT growth of approximately 39%. The Board recommended a final dividend of Rs 7 per share (70% payout) subject to shareholder approval. The statutory auditors issued an unmodified (clean) opinion. Key management changes include Mr. Amit Goriwale stepping down as Interim CFO & CRO (effective May 31, 2026) and Mr. Chirag Kothari being appointed as the new CFO & CRO (effective June 1, 2026). An exceptional item of Rs 58 lakhs was recorded due to the implementation of the Code on Social Security, 2020.
The company showed strong profitability improvement with PAT growth of ~39% despite flat revenue, indicating better cost management and operational efficiency. The clean audit opinion and dividend recommendation are positive signals for shareholders. The CFO transition appears planned and smooth.